Log in
Products
Latest News
FAQ
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Newest First
Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients
Phase 4
Recruiting
Conditions
Disorder Related to Renal Transplantation
Interventions
Drug: standard maintenance immunosuppression
Drug: Everolimus
Subscribe
First Posted Date
2024-09-05
Last Posted Date
2024-09-05
Lead Sponsor
University of Sao Paulo General Hospital
Target Recruit Count
80
Registration Number
NCT06584773
Locations
🇧🇷
Renal Transplantation Service, Sao Paulo, Brazil
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy